0.1201
price down icon1.96%   -0.0024
after-market After Hours: .12 -0.0001 -0.08%
loading
In 8 Bio Inc stock is traded at $0.1201, with a volume of 3.75M. It is down -1.96% in the last 24 hours and down -28.00% over the past month. IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
See More
Previous Close:
$0.1225
Open:
$0.1188
24h Volume:
3.75M
Relative Volume:
1.43
Market Cap:
$10.90M
Revenue:
-
Net Income/Loss:
$-31.88M
P/E Ratio:
-0.1601
EPS:
-0.75
Net Cash Flow:
$-25.20M
1W Performance:
-21.71%
1M Performance:
-28.00%
6M Performance:
-59.97%
1Y Performance:
-91.23%
1-Day Range:
Value
$0.1124
$0.1247
1-Week Range:
Value
$0.101
$0.1521
52-Week Range:
Value
$0.101
$1.74

In 8 Bio Inc Stock (INAB) Company Profile

Name
Name
In 8 Bio Inc
Name
Phone
(646) 600-6438
Name
Address
EMPIRE STATE BUILDING, NEW YORK
Name
Employee
18
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
INAB's Discussions on Twitter

Compare INAB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INAB
In 8 Bio Inc
0.1201 13.92M 0 -31.88M -25.20M -0.75
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-18-24 Initiated Laidlaw Buy
Aug-30-22 Initiated H.C. Wainwright Buy

In 8 Bio Inc Stock (INAB) Latest News

pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
May 29, 2025

Pre-market Movers: ALZN, HCTI, REVB, NTLA... - RTTNews

May 29, 2025
pulisher
May 29, 2025

Fierce Biotech Layoff Tracker 2025: Keros cuts 70 jobs; iTeos winds down - Fierce Biotech

May 29, 2025
pulisher
May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025
pulisher
May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025
pulisher
May 22, 2025

GRI Bio Presents Positive Pre-Clinical Data Demonstrating - GlobeNewswire

May 22, 2025
pulisher
May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025
pulisher
May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025
pulisher
May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewswire

May 12, 2025
pulisher
May 11, 2025

TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

8 Best Medical Simulators On Steam, Ranked - Game Rant

May 09, 2025
pulisher
May 09, 2025

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your RightsBLUE - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

TELA Bio Reports First Quarter 2025 Financial Results - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.

May 07, 2025
pulisher
May 07, 2025

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Nuvation Bio CFO to Share Latest Oncology Strategy at Exclusive Citizens Conference Next Week - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting - Yahoo Finance

Apr 29, 2025
pulisher
Apr 27, 2025

Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Tevogen Bio Announces 2025 Annual Meeting - GlobeNewswire

Apr 25, 2025
pulisher
Apr 20, 2025

TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN

Apr 20, 2025
pulisher
Apr 18, 2025

TELA Bio to Announce First Quarter 2025 Financial Results - The Manila Times

Apr 18, 2025
pulisher
Apr 17, 2025

Tevogen Bio Signs Agreement with CD 8 Technology - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Vyant Bio (OTCMKTS:VYNT) Trading 7.8% Higher – Time to Buy? - Defense World

Apr 15, 2025

In 8 Bio Inc Stock (INAB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Cap:     |  Volume (24h):